Sankyo Holdings Co., Ltd.
Records under this name other than patents Sankyo Holdings Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Sankyo Holdings Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,193,358 | Process for Producing High-Purity Prasugrel and Acid Addition Salt Thereof now held by UBE Corporation In force · High confidence | In force | High confidence | |
| US 7,265,131 | Isoquinolinone Derivatives and Their Use as Therapeutic Agents now held by Exelixis Patent Company LLC Term ended Term ended Jun 28, 2024 · High confidence | Term ended | Term ended Jun 28, 2024 | High confidence |
| US 7,772,272 | Method for Enhancing Glucose Uptake into Warm-Blooded Animal Adipocytes now held by Shimomura, Iichiro Term ended Ended no later than Apr 27, 2024 · Medium confidence | Term ended | Ended no later than Apr 27, 2024 | Medium confidence |
| US 9,345,671 | Adiponectin production enhancer now held by Shimomura, Iichiro, Matsuzawa, Yuji and Funahashi, Tohru Term ended Term ended Apr 27, 2024 · Medium confidence | Term ended | Term ended Apr 27, 2024 | Medium confidence |
| US 8,071,649 | Method for Treatment of Nocturia now held by Daiichi Sankyo Company, Limited Term ended Ended no later than Oct 1, 2022 · Low confidence | Term ended | Ended no later than Oct 1, 2022 | Low confidence |
| US 7,547,688 | Methods for Treatment of Nocturia now held by Daiichi Sankyo Company, Limited Term ended Term ended Sep 13, 2022 · Medium confidence | Term ended | Term ended Sep 13, 2022 | Medium confidence |
| US 8,071,763 | Methods for Treatment of Nocturia merged into Daiichi Sankyo Company, Limited Term ended Ended no later than Sep 13, 2022 · Low confidence | Term ended | Ended no later than Sep 13, 2022 | Low confidence |
| US 7,335,765 | Novel Nucleoside and Oligonucleotide Analogues now held by Daiichi Sankyo Company, Limited Term ended Term ended Jul 22, 2022 · High confidence | Term ended | Term ended Jul 22, 2022 | High confidence |
| US 7,527,790 | Methods of Reducing Bone Absorption Comprising Administering an Antibody That Binds Obm now held by Daiichi Sankyo Company, Limited Term ended Term ended Jun 29, 2022 · Medium confidence | Term ended | Term ended Jun 29, 2022 | Medium confidence |
| US 7,638,551 | Amino Alcohol Compounds or Phosphonic Acid Derivatives Thereof now held by Daiichi Sankyo Company, Limited Lapsed on the fee record Ended Dec 29, 2021 · Low confidence | Lapsed on the fee record | Ended Dec 29, 2021 | Low confidence |